CVE vs VET
Cenovus Energy Inc. and Vermilion Energy Inc., side by side — 10 fiscal years reported in CAD, drawn from SEC filings.
Most recent reported year
| Metric | CVE | VET |
|---|---|---|
| Revenue | CAD 49.7B | CAD 1.8B |
| Net income | CAD 3.9B | CAD -653.6M |
| Gross margin | · | · |
| Net margin | 7.9% | −37.0% |
| Return on equity | 12.8% | −26.0% |
| Diluted EPS | CAD 2.15 | −CAD 4.25 |
| Dividend / share | CAD 0.78 | CAD 0.52 |
| Payout ratio | 36.6% | −12.2% |
| Free cash flow | · | · |
| Equity | · | · |
| Net debt / equity | 0.26× | 0.55× |
| Current ratio | 1.57× | · |
| Revenue CAGR 5y | 29.7% | 9.1% |
| Profit CAGR 5y | · | · |
CVE bills 28.2× the revenue of VET, and VET closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | CVE | VET |
|---|---|---|
| FY2025 | CAD 49.7B | CAD 1.8B |
| FY2024 | CAD 54.3B | CAD 1.5B |
| FY2023 | CAD 52.2B | CAD 2.0B |
| FY2022 | CAD 66.9B | CAD 3.4B |
| FY2021 | CAD 46.4B | CAD 2.0B |
| FY2020 | CAD 13.5B | CAD 1.1B |
| FY2019 | CAD 20.5B | CAD 1.7B |
| FY2018 | CAD 20.8B | CAD 1.5B |
| FY2017 | CAD 17.0B | CAD 1.0B |
| FY2016 | CAD 11.0B | CAD 828.5M |
Bottom line
| Fiscal year | CVE | VET |
|---|---|---|
| FY2025 | CAD 3.9B | CAD -653.6M |
| FY2024 | CAD 3.1B | CAD -46.7M |
| FY2023 | CAD 4.1B | CAD -237.6M |
| FY2022 | CAD 6.5B | CAD 1.3B |
| FY2021 | CAD 587.0M | CAD 1.1B |
| FY2020 | CAD -2.4B | CAD -1.5B |
| FY2019 | CAD 2.2B | CAD 32.8M |
| FY2018 | CAD -2.7B | CAD 271.6M |
| FY2017 | CAD 3.4B | CAD 62.3M |
| FY2016 | CAD -545.0M | CAD -160.1M |
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +CAD 47,930,859,000 | CVE |
| FY2024 | +CAD 52,730,580,000 | CVE |
| FY2023 | +CAD 50,196,139,000 | CVE |
| FY2022 | +CAD 63,481,789,000 | CVE |
| FY2021 | +CAD 44,316,270,000 | CVE |
| FY2020 | +CAD 12,402,156,000 | CVE |
| FY2019 | +CAD 18,794,529,000 | CVE |
| FY2018 | +CAD 19,317,050,000 | CVE |
| FY2017 | +CAD 16,018,638,000 | CVE |
| FY2016 | +CAD 10,177,493,000 | CVE |
CVE has reported the higher revenue in every one of these 10 fiscal years. The gap has widened since the earliest year compared.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +44.9 pp | CVE |
| FY2024 | +8.8 pp | CVE |
| FY2023 | +19.7 pp | CVE |
| FY2022 | −28.8 pp | VET |
| FY2021 | −55.0 pp | VET |
| FY2020 | +115.4 pp | CVE |
| FY2019 | +8.8 pp | CVE |
| FY2018 | −30.6 pp | VET |
| FY2017 | +13.7 pp | CVE |
| FY2016 | +14.4 pp | CVE |
The higher net margin has changed hands between CVE and VET over this period.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
VET's net margin has been more volatile than CVE's over the 10 comparable fiscal years — 48.9 percentage points of standard deviation against 10.9.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CVE and VET over these 10 fiscal years — CVE led in 7 and VET in 3.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
VET's return on equity has been more volatile than CVE's over the 10 comparable fiscal years — 41.6 percentage points of standard deviation against 13.0.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CVE and VET over these 10 fiscal years — CVE led in 7 and VET in 3.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.